RT @LinHao_KL: Follow the paper published on @TheLancet’s on the latest of a China-developed #COVID19 vaccine - safe and induces an immune…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @hishamalsehli: نتائج مشجعه للقاح الصيني في المرحلة الثانيه من الدراسة. قد توثر الاصابه مسبقا بفيروس الادينوفايرس ٥ المستخدم كناقل للق…
the vaccine success in China belongs to all human-being
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
Recombinant adenovirus type-5-vectored #COVID19 vaccine in (n=603 phase 2 trial) • 1×10^11 & 5×10^10 viral particles dose groups • Neutralising antibodies in 59% & 47%, binding antibody in 96% & 97% • Adverse reactions in 72% & 74% of healt
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @LinHao_KL: Follow the paper published on @TheLancet’s on the latest of a China-developed #COVID19 vaccine - safe and induces an immune…
RT @HuubSchellekens: Twee goede, wetenschappelijk soliede, fase I studies met bemoedigende resultaten en met genuanceerd commentaar van de…
RT @Miss_Salmonella: La "vacuna china" también avanza a la fase 3, esto es la nueva "carrera espacial", la carrera espacial de nuestro sigl…
BREAKING NEWS: VACUNA / A INYECTARSE En 3 reportes diferente publicados hoy en The Lancet y el NEJM: 1) Spike https://t.co/L3o30DxqG3 2) Vector adenovirs; https://t.co/vFt6KAlvNn 3) mRNA https://t.co/5UpkCjNe5m https://t.co/tG93NtfVrN
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
@drtejams All studies are mentioned here. https://t.co/D7tVIhtMXj
RT @Miss_Salmonella: La "vacuna china" también avanza a la fase 3, esto es la nueva "carrera espacial", la carrera espacial de nuestro sigl…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @EricTopol: And another adenovirus vector vaccine Phase 2 trial (CanSIno) in China, published @TheLancet today, also found neutralizing…
https://t.co/S0We9gfhzO CanSino Biologics Incさん方、中国チームのご努力も賞賛したいです。Ad5-vectorって、既存vecorの一つですが、スマートに設計されたんですね。2dosesできちっと効果と安全性もみられてて敬服します。Ph3の成功を切に切に願ってます。別途、booser effectも見てください。
RT @FaridaAlHabib1: #الكويت اللقاح الصيني في مرحلته الثانية ناجعا في اكثر من 95% وبجرعة واحدة فقط وآمن أحدث ضجة مفرحة حول العالم بعد ان ن…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @BiotechMania: 中国カンシノ社が開発中のアデノウイルスベクターのCOVID-19ワクチンの第2相試験結果がLancetに掲載。 死亡率が高く最も重要な対象年齢である55歳以上で明らかに免疫反応が劣り、中和抗体陽性抗体価・陽性率が低いことは要注意だろう。 ht…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @Miss_Salmonella: La "vacuna china" también avanza a la fase 3, esto es la nueva "carrera espacial", la carrera espacial de nuestro sigl…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @BiotechMania: 中国カンシノ社が開発中のアデノウイルスベクターのCOVID-19ワクチンの第2相試験結果がLancetに掲載。 死亡率が高く最も重要な対象年齢である55歳以上で明らかに免疫反応が劣り、中和抗体陽性抗体価・陽性率が低いことは要注意だろう。 ht…
RT @pmarsupia: 🔴 Más buenas noticias! The Lancet también ha publicado los resultados de la Fase II de la farmacéutica china CanSino (sí,…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @FaridaAlHabib1: #الكويت اللقاح الصيني في مرحلته الثانية ناجعا في اكثر من 95% وبجرعة واحدة فقط وآمن أحدث ضجة مفرحة حول العالم بعد ان ن…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
Fantastic progress on #COVID19 vaccine development
RT @stefaniaconti: Via @TheLancetInfDis NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @AndyBiotech: #COVID19 The most interesting data point in Cansino Ph2 is that we see data for the 1st time for the most vulnerable older…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @AB_Algaissi: أخبار جميلة اليوم عن اللقاحات: نشر نتائج المرحلة السريرية ١ للقاح جامعة أكسفورد والنتائج مشجعة جداً. https://t.co/qzBJVYI…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
@manyez @fsg_monje Tb hay alguna buena noticia... https://t.co/WZ4bJnoKdH
sometimes I am very proud to be part of the scientific community one piece missing: the demonstration of T cell responses in PCR+ Ig- asymptomatic patients https://t.co/BN1bUGupw6 https://t.co/hWBEgIo6oK https://t.co/tMPWzUTtBi https://t.co/MhznLXJ73F http
Promising phase 1/2 work - looking forward to more data!!
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @BiotechMania: 中国カンシノ社が開発中のアデノウイルスベクターのCOVID-19ワクチンの第2相試験結果がLancetに掲載。 死亡率が高く最も重要な対象年齢である55歳以上で明らかに免疫反応が劣り、中和抗体陽性抗体価・陽性率が低いことは要注意だろう。 ht…
RT @YAYshamsaldeen: 💉🧬نتائج المرحلة الثانية(فاعلية تحفيز المناعة) لتطعيم 💉Ad5 vectored COVID-19💉 https://t.co/lZ1cWZh8bK ✅تأكيد المأمونية 👍…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @jesusanampa: Ad5-vectored #COVID19 vaccine in China - Phase 2 trial. n=508 -RBP antibodies peaked at day 28, seroconversion 96% -Signif…
RT @YAYshamsaldeen: 💉🧬نتائج المرحلة الثانية(فاعلية تحفيز المناعة) لتطعيم 💉Ad5 vectored COVID-19💉 https://t.co/lZ1cWZh8bK ✅تأكيد المأمونية 👍…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @Miss_Salmonella: La "vacuna china" también avanza a la fase 3, esto es la nueva "carrera espacial", la carrera espacial de nuestro sigl…
RT @Andy26473514: CCP派去銷毀證據的陳薇在柳葉刀上稱II期成功證明疫苗是安全的🤣🤣🤣 看看數據,4月找志願者的條件總結下來不就是「健康人群」嘛 嚴重不良反應9%,輕微中度不良反應低劑量都有74%⋯安慰劑組居然有37% 這不僅僅是疫苗有問題,怕是針管就不合格…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
@odiwuor_calvine @qulYAw8xGBUrafV @XHNews havent your white master told you how to search for news? tell me who made the vaccine? https://t.co/VajxM4CXFy
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
中国におけるワクチン。recombinant adenovirus type-5-vectorを使用 https://t.co/HnF3CogbK0
RT @HuubSchellekens: Twee goede, wetenschappelijk soliede, fase I studies met bemoedigende resultaten en met genuanceerd commentaar van de…
RT @pmarsupia: 🔴 Más buenas noticias! The Lancet también ha publicado los resultados de la Fase II de la farmacéutica china CanSino (sí,…
RT @YAYshamsaldeen: 💉🧬نتائج المرحلة الثانية(فاعلية تحفيز المناعة) لتطعيم 💉Ad5 vectored COVID-19💉 https://t.co/lZ1cWZh8bK ✅تأكيد المأمونية 👍…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
También se publicaron ayer en @TheLancet los resultados de fase 2 de otro prototipo de vacuna, en este caso de China 🔽 https://t.co/1RwwMQL4PR
RT @Miss_Salmonella: La "vacuna china" también avanza a la fase 3, esto es la nueva "carrera espacial", la carrera espacial de nuestro sigl…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
La "vacuna china" también avanza a la fase 3, esto es la nueva "carrera espacial", la carrera espacial de nuestro siglo. #COVID19
RT @YAYshamsaldeen: 💉🧬نتائج المرحلة الثانية(فاعلية تحفيز المناعة) لتطعيم 💉Ad5 vectored COVID-19💉 https://t.co/lZ1cWZh8bK ✅تأكيد المأمونية 👍…
Étude du The Lancet 😏
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: The primary objective of the study was to evaluate the immune response and safety of the vaccine, and to determine the most…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
Hope Chinese vaccine will soon conclude all testing, and be offered as a global public product for all.
RT @wszczeklik: Dzisiaj już o tym wspominałem - kolejne skuteczne szczepionki przechodzą dalsze fazy badań. Poniżej link do prac źródłowych…
RT @YAYshamsaldeen: 💉🧬نتائج المرحلة الثانية(فاعلية تحفيز المناعة) لتطعيم 💉Ad5 vectored COVID-19💉 https://t.co/lZ1cWZh8bK ✅تأكيد المأمونية 👍…
Vacuna chiná #covıd19.... Seguimos avanzando!
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @DrNecmettinUnal: Bu gün Lancette iki ayrı #covid19 aşısı ile alakalı makale yayınlandı. İlki Oxford'dan Faz1/2, ikincisi Çinden Faz2 ar…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @HuubSchellekens: Twee goede, wetenschappelijk soliede, fase I studies met bemoedigende resultaten en met genuanceerd commentaar van de…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @HuubSchellekens: Twee goede, wetenschappelijk soliede, fase I studies met bemoedigende resultaten en met genuanceerd commentaar van de…
Twee goede, wetenschappelijk soliede, fase I studies met bemoedigende resultaten en met genuanceerd commentaar van de Lancet. Gaat de goede kant op met het vaccin ondanks de smalende reacties van de gekkies op Twitter.